Skip to main content
N

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Filings indexed 142 across all filing types
Latest filing 2026-02-25 Regulatory Filings
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 39 pages 1.2MB
Regulatory Filings
2026-02-25 English
Appendix 4D and Half Year Accounts 29 pages 1.8MB
Regulatory Filings
2026-02-23 English
2026 Half Year Results 4 pages 347.6KB
Regulatory Filings
2026-02-23 English
2026 Half Year Financial Results Investor Presentation 31 pages 2.9MB
Regulatory Filings
2026-02-23 English
Nanosonics commences Controlled Market Release of CORIS 1
Regulatory Filings
2026-02-19 English
Change in substantial holding 8 pages 464.1KB
Regulatory Filings
2026-02-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.